Literature DB >> 20452242

Assessing medication adherence of perinatally HIV-infected children using caregiver interviews.

Susannah M Allison1, Linda J Koenig, Stephanie L Marhefka, Rosalind J Carter, Elaine J Abrams, Marc Bulterys, Vicki Tepper, Paul E Palumbo, Pamela J Bachanas, John J Farley.   

Abstract

Medication adherence is critical for children's HIV treatment success, but obtaining accurate assessments is challenging when complex measurement technologies are not feasible. Our goal was to evaluate a multidimensional adherence interview designed to improve on existing adherence measures. Data from caregivers (N = 126) of perinatally infected children were analyzed to determine the ability of the revised interview guide to detect potential treatment nonadherence. Questions related to viral load (VL) on a bivariate level included proportion of doses taken in the previous 3 days and 6 months, caregivers' knowledge of prescribed dosing frequencies, and caregivers' reports of problems associated with medication administration. VL was not associated with 3-day recall of missed doses. In multivariate analyses, only caregiver knowledge of prescribed dosing frequencies was uniquely associated with VL. Our modified interview appears to successfully identify family struggles with adherence and to have the capacity to help clinicians address medication adherence challenges.
Copyright © 2010 Association of Nurses in AIDS Care. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20452242      PMCID: PMC2964376          DOI: 10.1016/j.jana.2010.02.006

Source DB:  PubMed          Journal:  J Assoc Nurses AIDS Care        ISSN: 1055-3290            Impact factor:   1.354


  21 in total

1.  Clinical assessment of medication adherence among HIV-infected children: examination of the Treatment Interview Protocol (TIP).

Authors:  S L Marhefka; J J Farley; J R Rodrigue; L L Sandrik; J W Sleasman; V J Tepper
Journal:  AIDS Care       Date:  2004-04

2.  The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials.

Authors:  Sharon Mannheimer; Gerald Friedland; John Matts; Carroll Child; Margaret Chesney
Journal:  Clin Infect Dis       Date:  2002-03-11       Impact factor: 9.079

3.  Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1.

Authors:  S L Gortmaker; M Hughes; J Cervia; M Brady; G M Johnson; G R Seage; L Y Song; W M Dankner; J M Oleske
Journal:  N Engl J Med       Date:  2001-11-22       Impact factor: 91.245

4.  Adherence to antiretroviral therapy among HIV-positive children: examination of the role of caregiver health beliefs.

Authors:  R G Steele; B Anderson; B Rindel; M L Dreyer; K Perrin; R Christensen; V Tyc; P M Flynn
Journal:  AIDS Care       Date:  2001-10

5.  Impact of zidovudine use on risk and risk factors for perinatal transmission of HIV. Perinatal AIDS Collaborative Transmission Studies.

Authors:  R J Simonds; R Steketee; S Nesheim; P Matheson; P Palumbo; L Alger; E J Abrams; S Orloff; M Lindsay; A D Bardeguez; P Vink; R Byers; M Rogers
Journal:  AIDS       Date:  1998-02-12       Impact factor: 4.177

6.  Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG).

Authors:  M A Chesney; J R Ickovics; D B Chambers; A L Gifford; J Neidig; B Zwickl; A W Wu
Journal:  AIDS Care       Date:  2000-06

7.  Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infection.

Authors:  Russell B Van Dyke; Sophia Lee; George M Johnson; Andrew Wiznia; Kathleen Mohan; Kenneth Stanley; Edward V Morse; Paul A Krogstad; Sharon Nachman
Journal:  Pediatrics       Date:  2002-04       Impact factor: 7.124

8.  Family experiences with pediatric antiretroviral therapy: responsibilities, barriers, and strategies for remembering medications.

Authors:  Stephanie L Marhefka; Linda J Koenig; Susannah Allison; Pamela Bachanas; Marc Bulterys; Linda Bettica; Vicki J Tepper; Elaine J Abrams
Journal:  AIDS Patient Care STDS       Date:  2008-08       Impact factor: 5.078

9.  Adherence to prescribed antiretroviral therapy in human immunodeficiency virus-infected children in the PENTA 5 trial.

Authors:  Diana M Gibb; Ruth L Goodall; Vania Giacomet; Laura McGee; Alex Compagnucci; Hermione Lyall
Journal:  Pediatr Infect Dis J       Date:  2003-01       Impact factor: 2.129

10.  Assessment of adherence to antiviral therapy in HIV-infected children using the Medication Event Monitoring System, pharmacy refill, provider assessment, caregiver self-report, and appointment keeping.

Authors:  John Farley; Susan Hines; Amy Musk; Sherley Ferrus; Vicki Tepper
Journal:  J Acquir Immune Defic Syndr       Date:  2003-06-01       Impact factor: 3.731

View more
  8 in total

1.  Relationship between viral load and self-report measures of medication adherence among youth with perinatal HIV infection.

Authors:  Ann Usitalo; Erin Leister; Katherine Tassiopoulos; Susannah Allison; Kathleen Malee; Mary E Paul; Renee Smith; Russell B Van Dyke; George R Seage; Claude A Mellins
Journal:  AIDS Care       Date:  2013-06-26

2.  Comprehensive evaluation of caregiver-reported antiretroviral therapy adherence for HIV-infected children.

Authors:  Rachel C Vreeman; Winstone M Nyandiko; Hai Liu; Wanzhu Tu; Michael L Scanlon; James E Slaven; Samuel O Ayaya; Thomas S Inui
Journal:  AIDS Behav       Date:  2015-04

3.  A preliminary study of psychiatric, familial, and medical characteristics of high-utilizing sickle cell disease patients.

Authors:  Patrick C Carroll; Carlton Haywood; Michelle R Hoot; Sophie Lanzkron
Journal:  Clin J Pain       Date:  2013-04       Impact factor: 3.442

4.  High Abundance of genus Prevotella in the gut of perinatally HIV-infected children is associated with IP-10 levels despite therapy.

Authors:  Urvinder S Kaur; Anita Shet; Niharika Rajnala; Bindu Parachalil Gopalan; Preeti Moar; Himanshu D; Balendra Pratap Singh; Rupesh Chaturvedi; Ravi Tandon
Journal:  Sci Rep       Date:  2018-12-05       Impact factor: 4.379

5.  Validation of a self-report adherence measurement tool among a multinational cohort of children living with HIV in Kenya, South Africa and Thailand.

Authors:  Rachel C Vreeman; Michael L Scanlon; Wanzhu Tu; James E Slaven; Carole I McAteer; Stephen J Kerr; Torsak Bunupuradah; Sararut Chanthaburanum; Karl-Günter Technau; Winstone M Nyandiko
Journal:  J Int AIDS Soc       Date:  2019-05       Impact factor: 5.396

Review 6.  Storyboarding HIV Infected Young People's Adherence to Antiretroviral Therapy in Lower- to Upper Middle-Income Countries: A New-Materialist Qualitative Evidence Synthesis.

Authors:  Lynn A Hendricks; Taryn Young; Susanna S Van Wyk; Catharina Matheï; Karin Hannes
Journal:  Int J Environ Res Public Health       Date:  2022-09-08       Impact factor: 4.614

7.  Relationship between viral load and behavioral measures of adherence to antiretroviral therapy in children living with human immunodeficiency virus in Latin America.

Authors:  Horacio A Duarte; Donald Robert Harris; Katherine Tassiopoulos; Erin Leister; Silvia Fabiana Biason de Moura Negrini; Flávia Faleiro Ferreira; Maria Letícia Santos Cruz; Jorge Pinto; Susannah Allison; Rohan Hazra
Journal:  Braz J Infect Dis       Date:  2015-03-03       Impact factor: 3.257

8.  Children and Adolescents with Perinatal HIV-1 Infection: Factors Associated with Adherence to Treatment in the Brazilian Context.

Authors:  Maria Letícia Santos Cruz; Claudete A Araújo Cardoso; Mariana Q Darmont; Paulo Dickstein; Francisco I Bastos; Edvaldo Souza; Solange D Andrade; Marcia D'All Fabbro; Rosana Fonseca; Simone Monteiro
Journal:  Int J Environ Res Public Health       Date:  2016-06-21       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.